Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Group A and C Meningococcal Polysaccharide Vaccine in Healthy Children Aged 2-6 Years
NCT04689191Phase 3Completed
- Sponsor
- Institute of Medical Biology
- Start
- Sep 2020
- Primary completion
- Apr 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of unconjugated meningococcal polysaccharide vaccine (serogroups A, C) in meningococcal meningitis, sponsored by Institute of Medical Biology. Started Sep 2020; status: completed.
02
Drugs
unconjugated meningococcal polysaccharide vaccine (serogroups A, C)
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT04689191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04689191.